Hartford, Connecticut-based Aetna Inc.'s stock finished Thursday's session 0.51% higher at $129.30, with a total trading volume of 2.45 million shares. Over the last month and the previous three months, the Company's shares have advanced 14.66% and 12.14%, respectively. Additionally, the stock has gained 20.67% since the start of this year. Shares of the Company are trading above their 50-day and 200-day moving averages by 10.11% and 12.01%, respectively. Moreover, shares of Aetna, which operates as a health care benefits company in the US, have a Relative Strength Index (RSI) of 60.96.
On November 14th, 2016, research firm Bernstein downgraded the Company's stock rating from 'Outperform' to 'Market Perform'.
On December 02nd, 2016, Aetna's Board of Directors declared a quarterly cash dividend of $0.25 per share on its common stock. The dividend is payable on January 27th, 2017, to shareholders of record at the close of business on January 12th, 2017. AET complete research report is just a click away and free at:
Shares in St. Louis, Missouri headquartered Centene Corp. rose 0.37%, ending yesterday's session at $56.94, with a total trading volume of 1.82 million shares. The stock is trading 5.31% below its 50-day moving average. Shares of the Company, which operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the US, have an RSI of 47.28.
On November 14th, 2016, research firm Bernstein upgraded the Company's stock rating from 'Market Perform' to 'Outperform'.
On December 05th, 2016, Tenet Healthcare and Centene announced that they have signed a new, three-year agreement providing Centene's and Health Net's members with in-network access to Tenet's hospitals, outpatient centers and employed physicians in 18 states. The new agreement integrates all of Centene's and Health Net's insurance products into a single contract, following Centene's acquisition of Health Net earlier this year. The complimentary report on CNC can be downloaded at:
On Thursday, Indianapolis, Indiana headquartered Anthem Inc.'s stock climbed 0.97%, to close the day at $146.61. A total volume of 960,552 shares was traded. The Company's shares have advanced 16.12% in the last one month, 16.07% in the previous three months, and 7.22% on an YTD basis. The stock is trading 13.45% above its 50-day moving average and 11.47% above its 200-day moving average. Additionally, shares of Anthem, which through its subsidiaries, operates as a health benefits company in the US, have an RSI of 69.74.
On November 15th, 2016, research firm Wells Fargo upgraded the Company's stock rating from 'Market Perform' to 'Outperform'.
On November 16th, 2016, Anthem announced that Scott Towers has been named president of the company's Dental business, effective November 28th, 2016. In his new role, Towers is responsible for developing strategy and managing the profit and loss for the Dental business. This includes accountability for product development, operations, underwriting, and network development. Since joining Anthem in 2009 as part of the Company's acquisition of DeCare Dental, Towers has been an integral part of the Dental business Leadership team. Most recently, Towers was responsible for Anthem's dental underwriting, product development and analytics. He has more than 20 year's experience in the dental benefits industry. Sign up for your complimentary research report on ANTM at:
Shares in Bloomfield, Connecticut headquartered Cigna Corp. ended the day 0.22% higher at $137.13, with a total trading volume of 1.12 million shares. The stock has gained 6.49% in the last one month and 6.76% in the previous three months. The Company's shares are trading above their 50-day and 200-day moving averages by 6.13% and 4.00%, respectively. Furthermore, shares of Cigna, which provides insurance and related products and services in the US and internationally, have an RSI of 57.97.
On November 30th, 2016, Cigna announced that it is investing in an integrated hi-tech/hi-touch approach to customer decision support and service. Starting January 01st, 2017, 1.2 million Cigna's commercial health plan customers will receive One Guide access to guided consultations via phone, mobile app and "Click-to-Chat" for choosing their benefits, building a personal health team of doctors, clinicians and coaches and reducing their health expenses through reward programs. Get free access to your research report on CI at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44-330-808-3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA